Kami Wagner

Kami Wagner, M.S., M.H.A., serves as the Director of R&D Quality- Clinical Auditing at Bristol Myers Squibb, overseeing a team of up to 10 contributors across multiple regions and participating in Health Authority inspections. With experience managing audit staff, developing audit schedules, and collaborating with stakeholders for optimal study strategies, Kami has held various leadership roles in Clinical Trials & Safety, focusing on Good Clinical Practice (GCP) audits and compliance. Prior to Bristol Myers Squibb, Kami worked in analytical and formulation chemistry at organizations such as NexMed, Wyeth Pharmaceuticals, and Tosoh Bioscience. Education includes a Master of Health Administration from Saint Joseph's University and a Master of Science in Analytical Chemistry from Lehigh University, along with certifications in regulatory affairs and health equity research.